CN110003243A - A kind of preparation method of oxacephem parent nucleus - Google Patents

A kind of preparation method of oxacephem parent nucleus Download PDF

Info

Publication number
CN110003243A
CN110003243A CN201910325931.1A CN201910325931A CN110003243A CN 110003243 A CN110003243 A CN 110003243A CN 201910325931 A CN201910325931 A CN 201910325931A CN 110003243 A CN110003243 A CN 110003243A
Authority
CN
China
Prior art keywords
preparation
reaction
parent nucleus
oxacephem
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910325931.1A
Other languages
Chinese (zh)
Inventor
王作弟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanxi Qian Xiu Pharmaceutical Co Ltd
Original Assignee
Shanxi Qian Xiu Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanxi Qian Xiu Pharmaceutical Co Ltd filed Critical Shanxi Qian Xiu Pharmaceutical Co Ltd
Priority to CN201910325931.1A priority Critical patent/CN110003243A/en
Publication of CN110003243A publication Critical patent/CN110003243A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D505/02Preparation
    • C07D505/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D505/10Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D505/12Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 substituted in position 7
    • C07D505/14Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 substituted in position 7 with hetero atoms directly attached in position 7
    • C07D505/16Nitrogen atoms
    • C07D505/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention discloses a kind of preparation methods of oxacephem parent nucleus, this method is with compound (I) for raw material, in organic solvent, after oxidation reaction first occurs with peroxide, it is reacted again with sodium thiosulfate, after completion of the reaction, extracts methylene chloride phase, after vacuum distillation, recrystallisation solvent is added and obtains final product oxacephem parent nucleus.The preparation method preparation manipulation of oxacephem parent nucleus of the present invention is simple, prepares that raw material is cheap and easy to get, and preparation cost is low, and reaction route is short, and molar yield is high, and the finished product purity (HPLC) for being easy to industrialize, and preparing is up to 99%.

Description

A kind of preparation method of oxacephem parent nucleus
Technical field
The present invention relates to chemicals synthesis technical fields, and in particular to a kind of preparation method of oxacephem parent nucleus.
Background technique
Oxacephem has been the sulphur of the cephem former heterocyclic system being substituted with an oxygen, i.e. 1 one azabicyclo of 5_ oxa- } 4,3, D] pungent 2_ alkene, the antibiotic containing this heterocycle is known as oxygen head and embraces carbapenem antibiotic, belong to third generation head and steep rhzomorph, correlative study refers to Out: the resisting gram-positive angle of the more corresponding cephem of oxacephem and the activity of negative bacterium have enhancing, and current oxygen head is embraced Carbapenem antibiotic has: latamoxef and Flomoxef etc., such antibiotic has has a broad antifungal spectrum, especially right to G+ bacterium, G- bacterium The S. aureus L-forms (MRSA) of methicillin resistance have very strong antibacterial activity, and existing oxacephem parent nucleus preparation process operating procedure is multiple Miscellaneous, conversion process is unstable, and the finished product purity of preparation is not high.
Summary of the invention
The purpose of the present invention is to solve the above-mentioned problems, provides a kind of preparation method of oxacephem parent nucleus.
Term explanation:
Oxacephem parent nucleus, i.e. (6R, 7R) -7- [(4- toluyl) amido] -3- chloromethyl -8- oxo -5- oxa- - 1- azabicyclo [4.2.0] oct-2-ene -2- carboxylic acid benzhydryl ester, chemical structural formula are as follows:
Compound (I), chemical structural formula is as follows:
To achieve the goals above, the present invention adopts the following technical scheme:
A kind of preparation method of oxacephem parent nucleus, including following preparation step:
(1), compound (I) and organic solvent are added into reaction vessel, temperature is controlled at 0~10 DEG C, stirred to complete Dissolution, reaction material liquid are transparent;
(2), the dichloromethane solution of peroxide is added into reaction material liquid, reaction temperature controls the reaction at 0~10 DEG C Time is 1~4h;
(3), step (2) after completion of the reaction, it is water-soluble that the sodium thiosulfate that mass fraction is 15% is added into reaction material liquid Liquid, reaction temperature control is at 0~30 DEG C, reaction time 4h;
(4), after completion of the reaction, stratification extracts to obtain methylene chloride phase to step (3), and after vacuum distillation, it is molten that crystallization is added Agent obtains crystal, crystal is washed with recrystallisation solvent, oxacephem parent nucleus is obtained after drying after filtering.
Further, the molar ratio of the compound (I), peroxide and sodium thiosulfate is 1:(1.3~3): (1.5 ~5), preferably 1:1.5:3.
Further, the organic solvent is methylene chloride, the one or two in chloroform.
Further, the recrystallisation solvent is one or both of methanol, ethyl alcohol.
Further, the peroxide is one of Peracetic acid, metachloroperbenzoic acid.
The preparation route of the method for the invention is as follows:
The beneficial effects of the present invention are: the preparation method preparation manipulation of oxacephem parent nucleus of the present invention is simple, system Standby raw material is cheap and easy to get, and preparation cost is low, and reaction route is short, and molar yield is high, the finished product purity for being easy to industrialize, and preparing (HPLC) up to 99%.
Specific embodiment
The following examples can make those skilled in the art that the present invention be more fully understood, but not limit in any way The present invention.
A kind of preparation method of oxacephem parent nucleus, including following preparation step:
(1), it is added into reaction vessel and organic solvent, temperature is controlled at 0~10 DEG C, stirring is reacted to being completely dissolved Feed liquid is transparent;
(2), the dichloromethane solution of peroxide is added into reaction material liquid, reaction temperature controls the reaction at 0~10 DEG C Time is 1~4h;
(3), step (2) after completion of the reaction, it is water-soluble that the sodium thiosulfate that mass fraction is 15% is added into reaction material liquid Liquid, reaction temperature control is at 0~30 DEG C, reaction time 4h;
(4), after completion of the reaction, stratification extracts to obtain methylene chloride phase to step (3), and after vacuum distillation, it is molten that crystallization is added Agent obtains crystal, crystal is washed with recrystallisation solvent, oxacephem parent nucleus is obtained after drying after filtering.
In this preferred embodiment, the molar ratio of the compound (I), peroxide and sodium thiosulfate be 1:(1.3~ 3): (1.5~5), preferably 1:1.5:3.
In this preferred embodiment, the organic solvent is methylene chloride, the one or two in chloroform
In this preferred embodiment, the recrystallisation solvent is one or both of methanol, ethyl alcohol.
In this preferred embodiment, the peroxide is Peracetic acid, metachloroperbenzoic acid
One of.
Embodiment: methylene chloride 100mL, compound (I) 10.0g (0.0159mol), temperature are added into reaction vessel Control is at 0~10 DEG C, and stirring is completely dissolved to compound (I), and reaction material liquid is transparent, and quality point is added dropwise into reaction material liquid Used time 30min is added dropwise, after dripping in the dichloromethane solution 41.2g (0.0239mol) for the metachloroperbenzoic acid that number is 10% Controlling reaction temperature is 0~10 DEG C, reaction time 2h, and after the reaction was completed, it is 15% that mass fraction is added into reaction material liquid Sodium thiosulfate solution 50ml (0.0475mol), control reaction temperature are 0~10 DEG C, reaction time 4h, stratification, Methylene chloride phase is extracted to obtain, vacuum distillation is dry, and 50ml methanol stirred crystallization is added, and crystal is obtained after filtering, crystal is used The washing of 30ml methanol, obtains oxacephem parent nucleus after drying.
The purity of oxacephem parent nucleus made from preparation method with high performance liquid chromatography (HPLC) detection embodiment is high The specific testing conditions of effect liquid phase chromatogram method (HPLC) are as follows:
Liquid chromatograph: Shimadzu LC-10AT VP;
Pillar: Shimadzu C-18 chromatographic column;
Flow velocity: 1.0ml/min;
Column temperature: 15~25 DEG C;
Mobile phase: 400ml purified water is mixed with 600ml acetonitrile, obtains mobile phase.
Detection wavelength: 254nm.
Testing result are as follows: the purity of oxacephem parent nucleus is 99.7006%.
It will be understood by those skilled in the art that above embodiments are only exemplary embodiments, without departing substantially from spirit of the invention In the case where range, a variety of variations can be carried out, replaced and changed.

Claims (5)

1. a kind of preparation method of oxacephem parent nucleus, which is characterized in that including following preparation step:
(1), compound (I) and organic solvent are added into reaction vessel, temperature is controlled at 0 ~ 10 DEG C, stirring to being completely dissolved, Reaction material liquid is transparent;
(2), the dichloromethane solution of peroxide is added into reaction material liquid, reaction temperature control is at 0 ~ 10 DEG C, the reaction time For 1 ~ 4h;
(3), step (2) after completion of the reaction, the sodium thiosulfate solution that mass fraction is 15% is added into reaction material liquid, instead Answer temperature control at 0 ~ 30 DEG C, reaction time 4h;
(4), after completion of the reaction, stratification extracts to obtain methylene chloride phase to step (3), and after vacuum distillation, recrystallisation solvent is added, Crystal is obtained after filtering, and crystal is washed with recrystallisation solvent, oxacephem parent nucleus is obtained after drying.
2. a kind of preparation method of oxacephem parent nucleus according to claim 1, which is characterized in that the compound (I), The molar ratio of peroxide and sodium thiosulfate is 1:(1.3 ~ 3): (1.5 ~ 5), preferably 1:1.5:3.
3. a kind of preparation method of oxacephem parent nucleus according to claim 1, which is characterized in that the organic solvent is One or two in methylene chloride, chloroform.
4. a kind of preparation method of oxacephem parent nucleus according to claim 1, which is characterized in that the recrystallisation solvent is One or both of methanol, ethyl alcohol.
5. a kind of preparation method of oxacephem parent nucleus according to claim 1, which is characterized in that the peroxide is One of Peracetic acid, metachloroperbenzoic acid.
CN201910325931.1A 2019-04-23 2019-04-23 A kind of preparation method of oxacephem parent nucleus Pending CN110003243A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910325931.1A CN110003243A (en) 2019-04-23 2019-04-23 A kind of preparation method of oxacephem parent nucleus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910325931.1A CN110003243A (en) 2019-04-23 2019-04-23 A kind of preparation method of oxacephem parent nucleus

Publications (1)

Publication Number Publication Date
CN110003243A true CN110003243A (en) 2019-07-12

Family

ID=67173539

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910325931.1A Pending CN110003243A (en) 2019-04-23 2019-04-23 A kind of preparation method of oxacephem parent nucleus

Country Status (1)

Country Link
CN (1) CN110003243A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS543088A (en) * 1977-06-06 1979-01-11 Shionogi & Co Ltd Preparation of 1-oxadethiacephalosporin
US4478997A (en) * 1977-02-15 1984-10-23 Shionogi & Co., Ltd. 1-Oxadethiacepham compounds
CN103254215A (en) * 2013-05-24 2013-08-21 浙江东邦药业有限公司 Preparation method of allyl chlorooxyl cephalosporin compound
CN106749335A (en) * 2016-11-29 2017-05-31 浙江新和成股份有限公司 A kind of preparation method and application of halo oxygen cephalo-type intermediate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478997A (en) * 1977-02-15 1984-10-23 Shionogi & Co., Ltd. 1-Oxadethiacepham compounds
JPS543088A (en) * 1977-06-06 1979-01-11 Shionogi & Co Ltd Preparation of 1-oxadethiacephalosporin
CN103254215A (en) * 2013-05-24 2013-08-21 浙江东邦药业有限公司 Preparation method of allyl chlorooxyl cephalosporin compound
CN106749335A (en) * 2016-11-29 2017-05-31 浙江新和成股份有限公司 A kind of preparation method and application of halo oxygen cephalo-type intermediate

Similar Documents

Publication Publication Date Title
CN105753867B (en) A kind of preparation method of improved AVM hereinafter Batan sodium midbody compound
CN101087791A (en) Method for producing L-biopterin
CN101812075B (en) Cefixime compound and novel preparation method thereof
Bukownik et al. Synthetic receptors. 3, 6-Anhydro-7-benzenesulfonamido-1, 7-dideoxy-4, 5-O-isopropylidene-D-altro-hept-1-ynitol: A useful component for the preparation of chiral water-soluble cyclophanes based on carbohydrate precursors
CN106749335B (en) A kind of preparation method and application of halogenated oxygen cephalo-type intermediate
CN110003243A (en) A kind of preparation method of oxacephem parent nucleus
CN105777780A (en) Method for preparing thiazoline enol ester
CN104277053B (en) A kind of preparation method of Cefodizime and its intermediate cefodizime acid
CN110143957A (en) The preparation method of Cefditoren pivoxil Cephalosporins ring-opening product
CN106588865B (en) Preparation method of (4S,6R) -4-bromomethyl-6-substituted methyl-2-oxo-1, 3-dioxane
US20200062720A1 (en) Novel preparation method for anti-gout drug lesinurad, and key intermediate thereof
CN110386889B (en) Synthesis method of NSC128981
KR102592374B1 (en) How to Convert Crude Ascomycin to Purified Pimecrolimus
CN111196862B (en) Refining method of sugammadex sodium
CN110003236A (en) A kind of preparation method of oxacephem parent nucleus intermediate
CN104910183B (en) A kind of synthetic method of flucloxacillin sodium-hydrate
CN103450182B (en) Preparation and purification methods of Retapamulin
CN113372344B (en) Synthesis method of chloro-hexatomic nitrogen-containing heterocyclic imidazole compound
CN104628718A (en) Method for synthesizing scopolamine and salts thereof
CN104610277B (en) A kind of method that allylic hydroxylating prepares oxacephems antibiotic key intermediate
CN110003241A (en) A kind of preparation method of latamoxef parent nucleus
CN110128340B (en) Synthesis method of quinolinone compounds
CN110028522A (en) A kind of preparation method of Flomoxef parent nucleus
CN111548358A (en) Synthesis and preparation method of cefepime side chain intermediate
CN110003242A (en) A kind of preparation method of Flomoxef acid contamination levels product

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190712

RJ01 Rejection of invention patent application after publication